The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood

Transfusion

Volumn 45, Issue 3, 2005, Pages 427-432

  Runkel, Stefan ^b   Haubelt, Hannelore ^b   Hitzler, Walter ^b   Hellstern, Peter ^a  

^a Inst Hemostaseology/Transfus Med   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; FIBRINOGEN; IMMUNOGLOBULIN G; LEUKOCYTE ELASTASE; PROTEIN S; PROTHROMBIN;

ADULT; ARTICLE; BLOOD COMPONENT; CONTROLLED STUDY; FEMALE; FREEZING; HEMOSTASIS; HUMAN; LEUKAPHERESIS; MALE; NORMAL HUMAN; PLASMA; PROTEIN DEGRADATION; THAWING; THROMBOGENICITY;

ADULT; ANTICOAGULANTS; BLOOD COMPONENT REMOVAL; CITRIC ACID; FACTOR IX; FACTOR V; FACTOR VIII; FACTOR XI; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; LEUKOCYTE COUNT; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; PLASMA;

EID: 15244343858     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04276.x     Document Type: Article

References (20)

1. Smith JK. Quality of plasma for fractionation - does it matter? Transfus Sci 1994;15:343-50.
2. Hellstern P, Haubelt H. Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy. Thromb Res 2002;107(Suppl 1):S3-8.
3. Beeck H, Becker T, Kiessig ST, et al. The influence of citrate concentration on the quality of plasma obtained by automated plasmapheresis: a prospective study. Transfusion 1999;39:1266-70.
4. Riggert J, Simson G, Dittmann J, Koehler M. Prestorage leukocyte depletion with in-line filtration of whole blood in comparison with blood component depletion. Vox Sang 1995;69:201-5.
5. Rapaille A, Moore G, Siquet J, Flament J, Sondag-Thull D. Prestorage leukocyte reduction with in-line filtration of whole blood: evaluation of red cells and plasma storage. Vox Sang 1997;73:28-35.
6. Riggert J, Schwartz DW, Wieding JU, Mayr WR, Koehler M. Prestorage inline filtration of whole blood for obtaining white cell-reduced blood components. Transfusion 1997;37:1039-44.
7. Cardigan R, Sutherland J, Garwood M, et al. The effect of leukocyte depletion on the quality of fresh-frozen plasma. Br J Haematol 2001;114:233-40.
8. Chabanel A, Sensebé I, Masse M, et al. Quality assessment of seven types of fresh-frozen plasma leucoreduced by specific plasma filtration. Vox Sang 2003;84:308-17.
9. Solheim BG, Flesland O, Brosstad F, Mollnes TE, Seghatchian J. Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood. Transfus Apher Sci 2003;29:133-9.
10. Williamson LM, Rider JR, Swann ID, et al. Evaluation of plasma and red cells obtained after leucocyte depletion of whole blood. Transfus Med 1999;9:51-61.
11. Smith JF, Ness PM, Moroff G, Luban NL. Retention of coagulation factors in plasma frozen after extended holding at 1-6°C. Vox Sang 2000;78:28-30.
12. Tran-Mi B, Storch H, Seidel K, et al. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers. Vox Sang 2004;86:189-97.
13. Hellstern P, Bach J, Haubelt H, et al. The impact of the intensity of serial automated plasmapheresis and the speed of deep-freezing on the quality of plasma. Transfusion 2001;41:1601-5.
14. Evans D, Walker T, Evans H. Pilot scale (300 kg) fractionation of plasma for factor VIII and factor IX. Transfus Sci 1989;10:313-9.
15. Dzik WH, Rubner MA, Linehan SK. Refreezing previously thawed fresh-frozen plasma - stability of coagulation factors V and VIII: C. Transfusion 1989;29:600-4.
16. Hellstern P, Sachse H, Schwinn H, Oberfrank K. Manufacture and in vitro characterization of a solvent/detergent-treated human plasma. Vox Sang 1992;63:178-85.
17. Griffin B, Bell K, Prowse C. Studies on the procurement of blood coagulation factor VIII: in vitro studies on blood components prepared in half-strength citrate anticoagulant 18 hours after phlebotomy. Vox Sang 1988;55:9-13.
18. Suontaka AM, Åkerblom O, Blombäck M, et al. Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant. Vox Sang 1996;71:97-102.
19. Solheim BG, Bergerud UE, Kjeldsen-Kragh J, et al. Improved blood preservation with 0.5CPD Erythro-Sol. coagulation factor VIII activity and erythrocyte quality after delayed separation of blood. Vox Sang 1998;74:168-75.
20. Prowse C, Waterston YG, Dawes J, Farrugia A. Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant. Vox Sang 1987;52:257-64.